Skip to main content
Premium Trial:

Request an Annual Quote

UCB Pharma to Use Entelos PhysioLab for Rheumatoid Arthritis Research

NEW YORK (GenomeWeb News) - Entelos said today that UCB Pharma will use its PhysioLab biosimulation platform for rheumatoid arthritis research.
 
The Rheumatoid Arthritis PhysioLab is a predictive computer model that simulates arthritic patients and drug effects.
 
The company said that researchers use the system to select targets and compounds, find the best doses for patients, and support clinical trial design.
 
Financial terms of the agreement were not disclosed.